GT

Geeta Tushar Deore

Active Director Designated Partner DIN 10146278
DIN 10146278 First appointment May 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Geeta Tushar Deore

Data last updated:

Geeta Tushar Deore is a Designated Partner at Curanest Pharma Llp (since 2023). The company operates in Business Services.

DIN 10146278
Primary Designation Designated Partner
Industry Business Services
First Appointment 03 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 May 20232023Active

Board colleagues of Geeta Tushar Deore

NameDINCompanyDesignation
Nikhil Subhash Aher10146277Curanest Pharma LlpDesignated Partner
Sudhir Bhikaji Bhambar10146276Curanest Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curanest Pharma Llp
Premium access

Shareholding and investment profile for Geeta Tushar Deore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geeta Tushar Deore

Geeta Tushar Deore currently holds 1 directorship: Curanest Pharma Llp (Designated Partner, since 03 May 2023).

Geeta Tushar Deore was first appointed on 03 May 2023 as Designated Partner at Curanest Pharma Llp.

The current boards of Geeta Tushar Deore's companies include Nikhil Subhash Aher (Curanest Pharma Llp), Sudhir Bhikaji Bhambar (Curanest Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available